LeonaBio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2018
Net Income	-105.61	-96.94	-117.67	-95.64	-54.85	Upgrade
Depreciation & Amortization	0.97	0.97	0.97	0.85	0.48	Upgrade
Loss (Gain) From Sale of Assets	-	0.01	-	-	-	Upgrade
Asset Writedown & Restructuring Costs	67.66	-	-	-	-	Upgrade
Loss (Gain) From Sale of Investments	-0.33	-0.52	-1.41	-0.42	0.49	Upgrade
Stock-Based Compensation	6.1	11.05	10.62	10.61	4.62	Upgrade
Other Operating Activities	4.85	0.24	0.21	0.2	0.16	Upgrade
Change in Accounts Receivable	-	-	1.23	1.11	-1.04	Upgrade
Change in Accounts Payable	-21.34	-5.75	7.37	2.1	5.15	Upgrade
Change in Other Net Operating Assets	1.97	-6.23	-2.07	8.73	1.89	Upgrade
Operating Cash Flow	-45.73	-97.17	-100.75	-72.47	-43.1	Upgrade
Capital Expenditures	-	-0.03	-0.3	-1.14	-1.57	Upgrade
Investment in Securities	-15.89	54.86	95.39	58.81	-2.51	Upgrade
Investing Cash Flow	-15.89	54.83	95.09	57.66	-4.08	Upgrade
Issuance of Common Stock	90.03	0.19	0.49	0.65	97.09	Upgrade
Other Financing Activities	-7.57	-	-	-	-	Upgrade
Financing Cash Flow	82.46	0.19	0.49	0.65	97.09	Upgrade
Net Cash Flow	20.84	-42.15	-5.17	-14.15	49.91	Upgrade
Free Cash Flow	-45.73	-97.2	-101.06	-73.61	-44.67	Upgrade
Free Cash Flow Per Share	-10.70	-25.26	-26.58	-19.51	-12.10	Upgrade
Levered Free Cash Flow	22.47	-60.51	-60.9	-36.5	-31.15	Upgrade
Unlevered Free Cash Flow	22.47	-60.51	-60.9	-36.5	-31.15	Upgrade
Change in Working Capital	-19.38	-11.98	6.53	11.94	6.01	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.